blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2611908

EP2611908 - CELL CULTURE SCREEN FOR AGENTS THAT CONTROL ADIPOGENESIS AND MYOFIBROBLAST DIFFERENTIATION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  08.01.2016
Database last updated on 05.10.2024
Most recent event   Tooltip08.01.2016Application deemed to be withdrawnpublished on 10.02.2016  [2016/06]
Applicant(s)For all designated states
The Regents of the University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607 / US
[N/P]
Former [2013/28]For all designated states
The Regents of the University of California
1111 Franklin Street 12th Floor
Oakland, CA 94607-5200 / US
Inventor(s)01 / BISSELL, Mina, J.
854 Euclid Avenue
Berkeley, CA 94708 / US
02 / TURLEY, Eva, A.
1-517 Dufferin Avenue
London, Ontario N6B 2A3 / CA
03 / BAHRAMI, Seyed Bahram
6363 Christie Avenue Apt. 1726
Emeryville, CA 94608 / US
 [2013/28]
Representative(s)Chapman, Lee Phillip
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[2013/28]
Application number, filing date11822599.431.08.2011
WO2011US50054
Priority number, dateUS20100380125P03.09.2010         Original published format: US 380125 P
US20100379265P01.09.2010         Original published format: US 379265 P
[2013/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012031015
Date:08.03.2012
Language:EN
[2012/10]
Type: A1 Application with search report 
No.:EP2611908
Date:10.07.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 08.03.2012 takes the place of the publication of the European patent application.
[2013/28]
Search report(s)International search report - published on:US08.03.2012
(Supplementary) European search report - dispatched on:EP05.03.2014
ClassificationIPC:C12N5/071
[2013/28]
CPC:
C12N5/0653 (EP,US); C12N5/0602 (KR); G01N33/5073 (US);
A61K49/0008 (US); C12Q1/02 (KR); G01N33/5044 (EP,US);
C12N2503/02 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/28]
TitleGerman:ZELLKULTURSIEB FÜR MITTEL ZUR STEUERUNG VON ADIPOGENESE UND MYOFIBROBLASTENDIFFERENZIERUNG[2013/28]
English:CELL CULTURE SCREEN FOR AGENTS THAT CONTROL ADIPOGENESIS AND MYOFIBROBLAST DIFFERENTIATION[2013/28]
French:CRIBLAGE DE CULTURE CELLULAIRE POUR AGENTS RÉGULANT L'ADIPOGENÈSE ET LA DIFFÉRENCIATION MYOFRIBROPLASTIQUE[2013/28]
Entry into regional phase21.03.2013National basic fee paid 
21.03.2013Search fee paid 
21.03.2013Designation fee(s) paid 
21.03.2013Examination fee paid 
Examination procedure21.03.2013Examination requested  [2013/28]
25.09.2014Amendment by applicant (claims and/or description)
25.02.2015Despatch of a communication from the examining division (Time limit: M06)
08.09.2015Application deemed to be withdrawn, date of legal effect  [2016/06]
06.10.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2016/06]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.02.2015
Fees paidRenewal fee
27.08.2013Renewal fee patent year 03
27.08.2014Renewal fee patent year 04
27.08.2015Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]EP1158044  (HELIX RES INST [JP]) [X] 1-9,11-15 * paragraphs [0017] , [0028] , [0 33] , [0 46]; example 3; claim 3 *;
 [X]WO0044882  (ZEN BIO INC [US], et al) [X] 1-15 * page 11, line 1 - line 28 * * page 12, line 11 - line 15 * * page 17, line 7 - page 18, line 5 *;
 [X]  - BABISH JOHN G ET AL, "Antidiabetic Screening of Commercial Botanical Products in 3T3-L1 Adipocytes and db/db Mice", JOURNAL OF MEDICINAL FOOD, (201006), vol. 13, no. 3, ISSN 1096-620X, pages 535 - 547, XP002720606 [X] 1-9,11-15 * page 536, column r, paragraph l *

DOI:   http://dx.doi.org/10.1089/jmf.2009.0110
International search[X]US2005008621  (KIRKLAND JAMES [US], et al);
 [Y]US2009176306  (TAIRA TOSHIO [JP], et al);
 [Y]US7576052  (KAHN C RONALD [US], et al);
 [Y]US2009298164  (CATTADORIS HENRY J [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.